The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis

NCT05235711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2024-10-09

No results posted yet for this study

Summary

The purpose of the study is to investigate the role of the human immune response to candidemia/invasive candidiasis as it relates to the cytokine interferon-gamma.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Paschalis Vergidis, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-10
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05235711 on ClinicalTrials.gov